Name:
  • Norepinephrine
Other Names:
  • Levophed

Classification:

  • Sympathomimetic

Mechanism of Action:

  • Stimulates alpha and beta receptors, primarily alpha
  • + inotrope
  • + Chronotrope
  • Increases coronary artery blood flow
  • Causes severe vasoconstriction (increasing SVR)

Indications:

  • Septic shock
  • Neurogenic shock
  • Cardiogenic shock

Contraindications:

  • Hypovolemia (hemorrhage, dehydration)

Precautions:

  • Monitor BP every 2 - 5 min until stable
  • Monitor Urinary Output
  • Monitor IV site carefully, extravasations can cause necrosis, notify receiving
  • Monitor perfusion of extremities
  • Use cautiously in patients with cardiac history
  • Use cautiously in the elderly
  • Use cautiously in patients with hyperthyroidism

Adverse Effects:

  • May increase myocardial ischemia

Dose:

  • Mix 8 mg in 250 ml bag of D5W
  • Initiate an infusion via infusion pump at 0.05 to 0.1 mcg/kg/min. Adjust infusion rate in increments of 0.05 to 0.1 mcg/kg/min as frequently as q1-5 min to achieve/maintain target blood pressure. The usual max dose is 1 mcg/kg/min.
Routes:
  • IV
Special Notes:
  • Norepinephrine must be given through an infusion pump.
  • Most shock states require fluid administration prior to vasopressors therefore normal saline should be initiated prior to norepinephrine administration.
  • It is recommended to administer a normal saline infusion by gravity with any norepinephrine infusion. To do this:
    • Initiate a normal saline infusion at a rate appropriate to patient condition via gravity (i.e., not through the pump)
    • Connect the norepinephrine infusion (via the pump) to the access port of the normal saline infusion line proximal to the patient
    • This will help as a driver when volumes of medication being infused are small
  • Focus on fluid administration in patients with hypovolemic shock.
  • Epinephrine is the vasopressor of choice within the EHS ground ambulance system for pediatric patients ≤ 16 years of age.
  • May cause fetal anoxia when used in pregnancy.
  • Pregnancy category D [potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g., if it is required in a life-threatening situation)]
References:
  • Compendium of Pharmaceuticals and Specialties (CPS)
  • Pharmacology for the Prehospital Provider 2nd Edition  

Modifié le: mercredi, 26 mars 2025, 16:30